<bill session="117" type="h" number="8010" updated="2022-12-29T17:18:48Z">
  <state datetime="2022-06-09">REFERRED</state>
  <status>
    <introduced datetime="2022-06-09"/>
  </status>
  <introduced datetime="2022-06-09"/>
  <titles>
    <title type="display">More Options for Infants and Parents Act of 2022</title>
    <title type="short" as="introduced">More Options for Infants and Parents Act of 2022</title>
    <title type="official" as="introduced">To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to act upon pending submissions for new infant formula, to increase regulatory flexibility in the event of an infant formula shortage, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="G000558"/>
  <cosponsors>
    <cosponsor bioguide_id="A000377" joined="2022-06-09"/>
    <cosponsor bioguide_id="B001257" joined="2022-06-09"/>
    <cosponsor bioguide_id="B001275" joined="2022-06-09"/>
    <cosponsor bioguide_id="C001103" joined="2022-06-09"/>
    <cosponsor bioguide_id="D000628" joined="2022-06-09"/>
    <cosponsor bioguide_id="F000465" joined="2022-08-19"/>
    <cosponsor bioguide_id="G000568" joined="2022-06-09"/>
    <cosponsor bioguide_id="J000302" joined="2022-06-09"/>
    <cosponsor bioguide_id="M001180" joined="2022-06-09"/>
  </cosponsors>
  <actions>
    <action datetime="2022-06-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-06-09" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T15:01:27Z" status="Introduced in House">More Options for Infants and Parents Act of 2022

This bill requires the Food and Drug Administration (FDA) to (1) act upon any pending applications from domestic manufacturers for new infant formula within 14 days of the bill's enactment, and (2) maintain a list on its website of infant formula products that may be substituted for certain specialized infant formula products that are in shortage. It also authorizes the FDA to waive certain labeling and nutritional requirements in furtherance of other necessary infant formula product substitutions.</summary>
</bill>
